Interstitial collagenase and the ED-B oncofetal domain of fibronectin are markers of angiogenesis in human skin tumors.
Collagenase-1 (C1) is the predominant matrix metalloproteinase present in newly formed microvessels and serves as a marker of neovascularization. The expression of the oncofetal fragment of fibronectin (Fn-f) was found to be increased during angiogenesis. In the present study, we investigated the relationship between the expression of collagenase-1 and the oncofetal fragment of fibronectin in newly formed microvessels as markers of tumor angiogenesis. In aggressive skin tumors (i.e., morpheaform and recurrent basal cell carcinomas) and squamous cell carcinomas, neovascularization was associated with a marked increase in the number of C1-positive and Fn-f-positive microvessels. At the beginning of elongation, microvessels begin to produce C1 but lose their ability to express type IV collagen and FVIII-related antigen. Later, this endothelium produces both Fn-f and C1. As maturation of microvessels occurs, C1-containing endothelium fails to express Fn-f but begins to produce a type IV collagen-containing basement membrane and FVIII-related antigen. These studies show that there is a selective expression of both Fn-f and collagenase by immature endothelial cells. C1 production begins at early stages of blood vessel formation and continues throughout angiogenesis. In contrast, Fn-f expression is limited to later stages of vasculogenesis, indicating that these proteins are reliable markers of angiogenesis.
Karelina
T V
TV
Division of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Eisen
A Z
AZ
D000951:Antigens, Neoplasm / Q000276:immunology; D015415:Biomarkers; D003094:Collagen / Q000378:metabolism; D017364:Collagenases / Q000096:biosynthesis* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000201:enzymology / Q000378:metabolism; D005353:Fibronectins / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D020781:Matrix Metalloproteinase 1; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D012878:Skin Neoplasms / Q000098:blood supply* / Q000201:enzymology / Q000378:metabolism / Q000473:pathology
D000951:Antigens, Neoplasm; D015415:Biomarkers; D005353:Fibronectins; C031192:oncofetal antigens; D003094:Collagen; D017364:Collagenases; D020781:Matrix Metalloproteinase 1